18 min listen
Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96
Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96
ratings:
Length:
10 minutes
Released:
Nov 26, 2018
Format:
Podcast episode
Description
Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.
Guest: Susan Feeney, DNP, FNP-BC
Landing Page:
https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b
Guest: Susan Feeney, DNP, FNP-BC
Landing Page:
https://www.pri-med.com/online-education/Podcast/96-statin-therapy-frankly-speaking.aspx#sm.0000akbf5ldmtfh2s4u14ah34rz3b
Released:
Nov 26, 2018
Format:
Podcast episode
Titles in the series (100)
Helping Kidney Stones Pass: Use of Alpha Antagonists – Frankly Speaking EP7: In this podcast episode, we will talk about the benefits of alpha antagonists on passing larger kidney stones as well as discuss the need for stone collection and analysis to prevent future stones. We will also learn how to effectively counsel patients a... by Frankly Speaking About Family Medicine